Year All2026202520242023202220212020201920182017201620152014 ABIVAX’s ABX464 Phase IIa Data confirm HIV Reservoir Reduction in Oral Presentation at 8th International Workshop on HIV Persistence During Therapy December 15, 2017 Read More ABIVAX to present in plenary session at the 8th international conference on HIV persistence during therapy December 07, 2017 Read More ABIVAX to Present at German Equity Forum 2017 November 22, 2017 Read More ABIVAX enrolls first ulcerative colitis patient in new ABX464 proof-of-concept clinical trial November 20, 2017 Read More ABIVAX to Present at BIO-Europe® 2017 – 23rd Annual International Partnering Conference October 30, 2017 Read More ABIVAX presents novel data on the efficacy of its immune enhancer ABX196 in animal model of liver cancer at the World Vaccine Congress October 12, 2017 Read More ABIVAX expands Scientific Advisory Board with appointment of renowned virologist and former President of the Pasteur Institute, Prof. Christian Bréchot October 05, 2017 Read More ABIVAX secures an equity line financing with Kepler Cheuvreux September 28, 2017 Read More ABIVAX’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial September 28, 2017 Read More ABIVAX First-Half 2017 Financial Results and Update September 20, 2017 Read More
ABIVAX’s ABX464 Phase IIa Data confirm HIV Reservoir Reduction in Oral Presentation at 8th International Workshop on HIV Persistence During Therapy December 15, 2017 Read More
ABIVAX to present in plenary session at the 8th international conference on HIV persistence during therapy December 07, 2017 Read More
ABIVAX enrolls first ulcerative colitis patient in new ABX464 proof-of-concept clinical trial November 20, 2017 Read More
ABIVAX to Present at BIO-Europe® 2017 – 23rd Annual International Partnering Conference October 30, 2017 Read More
ABIVAX presents novel data on the efficacy of its immune enhancer ABX196 in animal model of liver cancer at the World Vaccine Congress October 12, 2017 Read More
ABIVAX expands Scientific Advisory Board with appointment of renowned virologist and former President of the Pasteur Institute, Prof. Christian Bréchot October 05, 2017 Read More
ABIVAX’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial September 28, 2017 Read More
